Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
4
×
national blog main
biotech
boston blog main
national top stories
san francisco blog main
san francisco top stories
boston top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
amgen
andrew oxtoby
babies
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
cancer diagnostics
ceo
cholesterol
clinical hold
clinical study
clinical trials
combination
commissioner
congress
crispr
crispr-cas9
data
delisting
democrats
departure
detroit blog main
What
medicine
4
×
week
4
×
announced
big
ceo
aces
area
based
bay
bio
biomedical
biopsy
bird
blood
bosley's
bosley’s
breakthroughs
bridge
bucks
buildout
cancer
cas
cholesterol
close
company
conference
crime
crispr
departure
developing
diego’s
drug
early
editas
ending
exit
firm
flexible
genomic
genomics
Language
unset
Current search:
week
×
medicine
×
" life sciences "
×
@xconomy.com
4 years ago
Early Bird Sale Ending for San Diego’s Xcelerating Life Sciences Conference
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More